Navigation Links
VIA Pharmaceuticals Announces Grant of New Patent on Lead Compound VIA-2291
Date:2/25/2009

-looking statements attributable to us or persons acting on our behalf are expressly qualified in their entirety by the cautionary statements set forth above. Forward-looking statements speak only as of the date they are made, and VIA undertakes no obligation to update publicly any of these statements in light of new information or future events.


'/>"/>
SOURCE VIA Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. Vion Pharmaceuticals Pays Interest on 7.75% Convertible Senior Notes
2. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
3. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
4. XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007
5. Cadence Pharmaceuticals Reports Second Quarter 2007 Financial Results
6. Nabi Biopharmaceuticals to Present at Upcoming Industry Conferences
7. Anadys Pharmaceuticals Appoints Steve Worland, Ph.D. as President and Chief Executive Officer
8. Poniard Pharmaceuticals Announces Participation in Upcoming Conferences
9. NovaQuest Advances Virtual Development Model With Strategic Investment in TOPIGEN Pharmaceuticals
10. Drug Royalty Corporation (DRC) Announces Acquisition Regarding PEG-INTRON(R) From Enzon Pharmaceuticals, Inc. (ENZN)
11. Sunesis Pharmaceuticals Announces Reorganization to Focus Resources and Build Value in Clinical-Stage Programs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/16/2009)... Martek Biosciences Corporation (Nasdaq: MATK ) ... and fiscal year ended October 31, 2009. Revenues for ... $90.4 million in the fourth quarter of fiscal 2008. ... share, for the fourth quarter of fiscal 2009, a ... diluted share, in last year,s fourth quarter. The ...
(Date:12/16/2009)... microgears in suspended solution by swimming , ... ... Scientists at the U.S. Department of Energy’s (DOE) Argonne National ... bacteria can turn microgears when suspended in a solution, providing ... , , ,“The gears are a million times more massive ...
(Date:12/16/2009)... -- Decision Resources, one of the world,s leading ... issues, finds that, according to responses from surveyed ... (both interleukin inhibitors) will capture 22 percent of ... market for moderate to severe psoriasis. Among these ... nearly three times as much patient share as ...
(Date:12/16/2009)... to Special Protocol Assessment with the Food ... 16 /PRNewswire-FirstCall/ - AEterna Zentaris Inc. (NASDAQ: ... a global biopharmaceutical company focused on oncology ... by its partner Keryx Biopharmaceuticals Inc. ("Keryx") ... clinical trial for perifosine (KRX-0401), the Company,s ...
Breaking Biology Technology:Martek Announces Fourth Quarter and FY 2009 Financial Results 2Martek Announces Fourth Quarter and FY 2009 Financial Results 3Martek Announces Fourth Quarter and FY 2009 Financial Results 4Martek Announces Fourth Quarter and FY 2009 Financial Results 5Martek Announces Fourth Quarter and FY 2009 Financial Results 6Martek Announces Fourth Quarter and FY 2009 Financial Results 7Martek Announces Fourth Quarter and FY 2009 Financial Results 8Martek Announces Fourth Quarter and FY 2009 Financial Results 9Martek Announces Fourth Quarter and FY 2009 Financial Results 10Martek Announces Fourth Quarter and FY 2009 Financial Results 11Martek Announces Fourth Quarter and FY 2009 Financial Results 12Martek Announces Fourth Quarter and FY 2009 Financial Results 13Martek Announces Fourth Quarter and FY 2009 Financial Results 14Argonne Scientists Use Bacteria to Power Simple Machines 2Argonne Scientists Use Bacteria to Power Simple Machines 3In 2012, Stelara and Briakinumab Will Capture 22 Percent of the Biologics Share in the Moderate to Severe Psoriasis Drug Market 2In 2012, Stelara and Briakinumab Will Capture 22 Percent of the Biologics Share in the Moderate to Severe Psoriasis Drug Market 3AEterna Zentaris Partner, Keryx, Initiates Phase 3 Registration Trial with Perifosine (KRX-0401) for the Treatment of Patients with Advanced Multiple Myeloma 2AEterna Zentaris Partner, Keryx, Initiates Phase 3 Registration Trial with Perifosine (KRX-0401) for the Treatment of Patients with Advanced Multiple Myeloma 3AEterna Zentaris Partner, Keryx, Initiates Phase 3 Registration Trial with Perifosine (KRX-0401) for the Treatment of Patients with Advanced Multiple Myeloma 4AEterna Zentaris Partner, Keryx, Initiates Phase 3 Registration Trial with Perifosine (KRX-0401) for the Treatment of Patients with Advanced Multiple Myeloma 5
... that resemble TV remotes are catching on in large ... ,But that doesn't mean students are kicking back and ... about a dozen buttons, let them respond instantly to ... an encouragement to some students who might feel embarrassed ...
... business, the online reality is that many Internet users still ... Internet surfers often believe they know a good Web site ... number of surface-level factors. For example, surfers are more likely ... results of a search engine query than when it appears ...
... Wisconsin-Madison says it has bought a new copy machine for ... better "enlarge" feature than the typical office copier: It makes ... helixes and the Anthrax virus. , ,Using white polymer powder ... inches tall one layer at a time. Z-Corp is headquartered ...
Other Biology Technology:Many still distrust Web sites is yours credible enough? 2Many still distrust Web sites is yours credible enough? 3
(Date:12/16/2009)... N.J., Dec. 9 BIO-key International, ... in finger-based biometric identification solutions, today announced ... most respected security publications, named BIO-key International ... the Access Control sub-category Biometrics. ,, (Logo: ... Peter Stephenson, technology editor, SC Magazine, "Biometric ...
(Date:12/15/2009)... as babies are born, they are susceptible to diseases ... to a month, their immune systems aren,t adequately developed ... they can lead to serious problems if left untreated. ... researchers have pinpointed a group of depleted white blood ... "We,re trying to improve the immune system of newborns ...
(Date:12/15/2009)... Laboratory, San Diego, California, has been awarded an ... based on results of a recent onsite inspection. ... of this national recognition and congratulated for the ... Inc. GenWay Clinical Laboratory is one of nearly ... Accreditation Program, begun in the early 1960s, is ...
Breaking Biology News(10 mins):BIO-key(R) Selected as 2009 Industry Innovator in Biometrics by SC Magazine 2BIO-key(R) Selected as 2009 Industry Innovator in Biometrics by SC Magazine 3Researchers work on vaccine to improve immune system in newborns 2LifeNet Health and Childrens Mercy Hospital Announce First Implant With MatrACELL 28TM 29 Technology 56777 1LifeNet Health and Childrens Mercy Hospital Announce First Implant With MatrACELL 28TM 29 Technology 56777 2LifeNet Health and Childrens Mercy Hospital Announce First Implant With MatrACELL 28TM 29 Technology 56777 3Reportlinker Adds World Botulinum Toxin Market Report 56773 1Reportlinker Adds World Botulinum Toxin Market Report 56773 2Reportlinker Adds World Botulinum Toxin Market Report 56773 3Reportlinker Adds World Botulinum Toxin Market Report 56773 4Reportlinker Adds World Botulinum Toxin Market Report 56773 5Reportlinker Adds World Botulinum Toxin Market Report 56773 6Reportlinker Adds World Botulinum Toxin Market Report 56773 7Reportlinker Adds World Botulinum Toxin Market Report 56773 8Reportlinker Adds World Botulinum Toxin Market Report 56773 9Reportlinker Adds World Botulinum Toxin Market Report 56773 10Reportlinker Adds World Botulinum Toxin Market Report 56773 11Reportlinker Adds World Botulinum Toxin Market Report 56773 12Reportlinker Adds US and European Radiopharmaceuticals Market Report 56769 1Reportlinker Adds US and European Radiopharmaceuticals Market Report 56769 2Reportlinker Adds US and European Radiopharmaceuticals Market Report 56769 3Reportlinker Adds US and European Radiopharmaceuticals Market Report 56769 4Reportlinker Adds US and European Radiopharmaceuticals Market Report 56769 5Reportlinker Adds US and European Radiopharmaceuticals Market Report 56769 6Reportlinker Adds US and European Radiopharmaceuticals Market Report 56769 7Reportlinker Adds US and European Radiopharmaceuticals Market Report 56769 8Reportlinker Adds US and European Radiopharmaceuticals Market Report 56769 9Reportlinker Adds US and European Radiopharmaceuticals Market Report 56769 10Reportlinker Adds US and European Radiopharmaceuticals Market Report 56769 11Reportlinker Adds US and European Radiopharmaceuticals Market Report 56769 12Reportlinker Adds US and European Radiopharmaceuticals Market Report 56769 13Reportlinker Adds US and European Radiopharmaceuticals Market Report 56769 14Reportlinker Adds US and European Radiopharmaceuticals Market Report 56769 15Reportlinker Adds US and European Radiopharmaceuticals Market Report 56769 16Reportlinker Adds US and European Radiopharmaceuticals Market Report 56769 17Reportlinker Adds US and European Radiopharmaceuticals Market Report 56769 18
... cholesterol" are good enough, a new study published in the ... that you may want to think again. In the report, ... that simply having high levels of good cholesterol (HDL) and ... heath. Instead, they show that the good cholesterol has varying ...
... pollutant that has a potent effect on gene activity, ... the December issue of BioScience . The chemical ... wood and textile preservative, and as a pesticide on ... Tributyltin affects sensitive receptors in the cells of animals, ...
... team of scientists from across Europe are embarking on new ... allergy affects around 10 million EU citizens and there is ... Food Research, a lead partner in the Food Allergy Specific ... do is avoid the foods to which they are allergic. ...
Other Biology News:Persistent pollutant may promote obesity 2Scientists developing food allergy treatment 2
karyopherin alpha2 (2G7)...
50 assays. Provides an easy system for rapid separation of cytosol and particulate fractions that are compatiable with downstream studies....
Eliminate electrical interference from any analog signal, without filtering. Ideal for electrophysiology applications like EKG, EMG, and EEGs. Removes 50/60hz noise and harmonics caused by grounding ...
... 400 Spun Columns, 10. *SizeSep 400 Spun ... 400 base pairs in length. - ... and pre-equilibrated in distilled water containing 0.15% Kathon ... ~ 400 base pairs. *Extremely useful ...
Biology Products: